Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
BunyaVax Logo
BunyaVax Growth Score
34
CB Rank
234179
Heat Score
57
BunyaVax exploits proprietary vaccine platform technology to develop safe and efficacious vaccines against infectious diseases and cancer.
Founded
obfuscation
PrivateGrant Lelystad, Flevoland, The Netherlands1-10 www.bunyavax.com/
Biotechnology
Health Care
Overview

BunyaVax
Total Funding
obfuscation
Growth Score
34
Heat Score
57

Total Funding
obfuscation
obfuscation
Grant raised
obfuscation
Growth Score34
-32 pts
in past quarter
Heat Score 57
-7 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About BunyaVax

CB Rank
234179
BunyaVax exploits proprietary vaccine platform technology to develop safe and efficacious vaccines against infectious diseases and cancer.
Founded
obfuscation
PrivateGrant Lelystad, Flevoland, The Netherlands1-10 www.bunyavax.com/
Biotechnology
Health Care

Funding Rounds

Grant
OBF
in
obfuscation

Key People

Details

Operating Status Active
Company Type For Profit
About the Company
BunyaVax exploits proprietary vaccine platform technology to develop safe and efficacious vaccines against infectious diseases and cancer. The unique ‘Plug and Play’ platforms are used to generate potent vaccines that can encode almost any antigen of interest. Applications are in the veterinary and human setting.
Contact Email info@bunyavax.com
Predictions & Insights

Growth Prediction

See this Growth Prediction

Products & Services

4s Technology-based Live Attenuated Vaccines
Live attenuated vaccines developed using 4s technology that split the M genome segment of bunyaviruses to create safer, four-segmented viruses for immunization against diseases like Rift Valley fever.
Rift Valley Fever Virus Neutralization Test (VNT)
A diagnostic assay using a genetically modified four-segmented Rift Valley fever virus expressing GFP, providing high sensitivity and specificity for detecting RVFV infection.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 1
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Grant - BunyaVax Logo
Grant - BunyaVax
1
obfuscation
— Grant
obfuscation
Grant - BunyaVax Logo
Grant - BunyaVax
1
obfuscation
— Grant
obfuscation
Grant - BunyaVax Logo
Grant - BunyaVax
1
obfuscation
— Grant
obfuscation
Grant - BunyaVax Logo
Grant - BunyaVax
1
obfuscation
— Grant
obfuscation
Grant - BunyaVax Logo
Grant - BunyaVax
1
obfuscation
— Grant

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 1
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Grant - BunyaVax Logo
Grant - BunyaVax
1
obfuscation
— Grant
obfuscation
Grant - BunyaVax Logo
Grant - BunyaVax
1
obfuscation
— Grant
obfuscation
Grant - BunyaVax Logo
Grant - BunyaVax
1
obfuscation
— Grant
obfuscation
Grant - BunyaVax Logo
Grant - BunyaVax
1
obfuscation
— Grant
obfuscation
Grant - BunyaVax Logo
Grant - BunyaVax
1
obfuscation
— Grant

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.
Investor Name  
Lead Investor  
Funding Round  
Partners  
EISMEA Logo
EISMEA
—
Grant - BunyaVax Logo
Grant - BunyaVax
—
EISMEA Logo
EISMEA
—
Grant - BunyaVax Logo
Grant - BunyaVax
—
EISMEA Logo
EISMEA
—
Grant - BunyaVax Logo
Grant - BunyaVax
—
EISMEA Logo
EISMEA
—
Grant - BunyaVax Logo
Grant - BunyaVax
—
EISMEA Logo
EISMEA
—
Grant - BunyaVax Logo
Grant - BunyaVax
—
Market Intelligence
People
View Profiles & Contacts
Headcount 1-10 Employee Profiles 2

Employee Profiles

News
Technology
View Tech Report

Monthly Web Visits

86
-5.49%
 in past month

IT Spend

$43.1KThis year, BunyaVax is projected to spend $43.1K on IT, according to Aberdeen.

Active Website Tech Count

3BunyaVax is actively using 3 technologies for its website, according to BuiltWith. These include Viewport Meta, CommonCrawl Top 50m, and  Euro.
Sub-Organizations
Frequently Asked Questions

Where is BunyaVax's headquarters? BunyaVax is located in Lelystad, Flevoland, The Netherlands.Who invested in BunyaVax? BunyaVax is funded by EISMEA.When was the last funding round for BunyaVax? BunyaVax closed its last funding round on
obfuscation
from a Grant round.Who are BunyaVax's competitors? Alternatives and possible competitors to BunyaVax may include Valneva, Emergent BioSolutions, and  GeoVax.How much funding has BunyaVax raised to date? BunyaVax has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(8c8a01a 1)
|